These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
730 related articles for article (PubMed ID: 30642292)
41. Gene Expression Signatures for Head and Neck Cancer Patient Stratification: Are Results Ready for Clinical Application? Tonella L; Giannoccaro M; Alfieri S; Canevari S; De Cecco L Curr Treat Options Oncol; 2017 May; 18(5):32. PubMed ID: 28474265 [TBL] [Abstract][Full Text] [Related]
42. Analysis of DNA methylation and gene expression in radiation-resistant head and neck tumors. Chen X; Liu L; Mims J; Punska EC; Williams KE; Zhao W; Arcaro KF; Tsang AW; Zhou X; Furdui CM Epigenetics; 2015; 10(6):545-61. PubMed ID: 25961636 [TBL] [Abstract][Full Text] [Related]
43. GDF15 contributes to radioresistance and cancer stemness of head and neck cancer by regulating cellular reactive oxygen species via a SMAD-associated signaling pathway. Li YL; Chang JT; Lee LY; Fan KH; Lu YC; Li YC; Chiang CH; You GR; Chen HY; Cheng AJ Oncotarget; 2017 Jan; 8(1):1508-1528. PubMed ID: 27903972 [TBL] [Abstract][Full Text] [Related]
44. Long Non-coding RNAs as Important Biomarkers in Laryngeal Cancer and Other Head and Neck Tumours. Cossu AM; Mosca L; Zappavigna S; Misso G; Bocchetti M; De Micco F; Quagliuolo L; Porcelli M; Caraglia M; Boccellino M Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336999 [TBL] [Abstract][Full Text] [Related]
45. Fibronectin 1 is a potential biomarker for radioresistance in head and neck squamous cell carcinoma. Jerhammar F; Ceder R; Garvin S; Grénman R; Grafström RC; Roberg K Cancer Biol Ther; 2010 Dec; 10(12):1244-51. PubMed ID: 20930522 [TBL] [Abstract][Full Text] [Related]
46. A Metabolic Gene Signature to Predict Overall Survival in Head and Neck Squamous Cell Carcinoma. Wu ZH; Tang Y; Zhou Y Mediators Inflamm; 2020; 2020():6716908. PubMed ID: 33456371 [TBL] [Abstract][Full Text] [Related]
47. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma. Song D; Tian J; Han X; Li X Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165 [TBL] [Abstract][Full Text] [Related]
48. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma. Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721 [TBL] [Abstract][Full Text] [Related]
49. Association between cancer stem cell gene expression signatures and prognosis in head and neck squamous cell carcinoma. Kim SI; Woo SR; Noh JK; Lee MK; Lee YC; Lee JW; Kong M; Ko SG; Eun YG BMC Cancer; 2022 Oct; 22(1):1077. PubMed ID: 36261806 [TBL] [Abstract][Full Text] [Related]
50. A novel panel of biomarkers predicts radioresistance in patients with squamous cell carcinoma of the head and neck. Akervall J; Nandalur S; Zhang J; Qian CN; Goldstein N; Gyllerup P; Gardinger Y; Alm J; Lorenc K; Nilsson K; Resau J; Wilson G; Teh B Eur J Cancer; 2014 Feb; 50(3):570-81. PubMed ID: 24332450 [TBL] [Abstract][Full Text] [Related]
51. RNA-Seq analysis of peripheral blood mononuclear cells reveals unique transcriptional signatures associated with radiotherapy response of nasopharyngeal carcinoma and prognosis of head and neck cancer. Liu G; Zeng X; Wu B; Zhao J; Pan Y Cancer Biol Ther; 2020; 21(2):139-146. PubMed ID: 31698994 [TBL] [Abstract][Full Text] [Related]
52. Xenograft assessment of predictive biomarkers for standard head and neck cancer therapies. Stein AP; Swick AD; Smith MA; Blitzer GC; Yang RZ; Saha S; Harari PM; Lambert PF; Liu CZ; Kimple RJ Cancer Med; 2015 May; 4(5):699-712. PubMed ID: 25619980 [TBL] [Abstract][Full Text] [Related]
53. Molecular Signature of Long Non-Coding RNA Associated with Areca Nut-Induced Head and Neck Cancer. Huang HH; You GR; Tang SJ; Chang JT; Cheng AJ Cells; 2023 Mar; 12(6):. PubMed ID: 36980216 [TBL] [Abstract][Full Text] [Related]
54. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients. Zhang C; Zhang CD; Ma MH; Dai DQ World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201 [TBL] [Abstract][Full Text] [Related]
55. A key genomic signature associated with lymphovascular invasion in head and neck squamous cell carcinoma. Zhang J; Lin H; Jiang H; Jiang H; Xie T; Wang B; Huang X; Lin J; Xu A; Li R; Zhang J; Yuan Y BMC Cancer; 2020 Mar; 20(1):266. PubMed ID: 32228488 [TBL] [Abstract][Full Text] [Related]
56. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival. Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751 [TBL] [Abstract][Full Text] [Related]
57. A radiosensitivity MiRNA signature validated by the TCGA database for head and neck squamous cell carcinomas. Liu N; Boohaker RJ; Jiang C; Boohaker JR; Xu B Oncotarget; 2015 Oct; 6(33):34649-57. PubMed ID: 26452218 [TBL] [Abstract][Full Text] [Related]
58. Cyclophilin B expression is associated with in vitro radioresistance and clinical outcome after radiotherapy. Williams PD; Owens CR; Dziegielewski J; Moskaluk CA; Read PW; Larner JM; Story MD; Brock WA; Amundson SA; Lee JK; Theodorescu D Neoplasia; 2011 Dec; 13(12):1122-31. PubMed ID: 22241958 [TBL] [Abstract][Full Text] [Related]
59. Molecular chaperones as a common set of proteins that regulate the invasion phenotype of head and neck cancer. Chiu CC; Lin CY; Lee LY; Chen YJ; Lu YC; Wang HM; Liao CT; Chang JT; Cheng AJ Clin Cancer Res; 2011 Jul; 17(14):4629-41. PubMed ID: 21642380 [TBL] [Abstract][Full Text] [Related]
60. Higher Expression of SPP1 Predicts Poorer Survival Outcomes in Head and Neck Cancer. Bie T; Zhang X J Immunol Res; 2021; 2021():8569575. PubMed ID: 34977258 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]